EUVIMEDEUVIMED entdecken
Crossref

Molecular Characterization of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae : mgrB Mutations and Clonal Diversity in Pediatric Intensive Care Isolates

Ayşe Hande Türk, Alper Tekeli iD, Duygu Öcal, Devran Gerçeker

Microbial Drug Resistance · 2025

DOI: 10.1089/mdr.2024.0110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2025. Verfasst von Ayşe Hande Türk und 3 weiteren Autor:innen. Beteiligte Einrichtung: Republic of Türkiye Ministry of Health, General Directorate of Public Health, National Molecular Microbiology Reference Laboratory, Ankara, Türkiye. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Anti-Bacterial Agents, Colistin, Carbapenems. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colistin- and carbapenem-resistant Klebsiella pneumoniae (ColR CrKp) cause important health problems in pediatric intensive care units (PICUs) due to its ability to harbor multiple resistance genes and spread of high-risk clones. In this study, molecular epidemiological characteristics, transferable resistance genes, and mgrB alterations of ColR CrKp isolated from PICU were investigated. Isolates were identified by MALDI-TOF MS, and antimicrobial susceptibility tests were performed using disk diffusion method, gradient strip test, and broth microdilution method. Extended spectrum beta-lactamase, AmpC beta-lactamase, carbapenemase, 16S rRNA methyltransferase, plasmid-mediated quinolone resistance, and mcr-1 to -5 genes were investigated by polymerase chain reaction. Sanger sequencing was performed to obtain bla OXA-48-like and mgrB sequences. Pulsed-field gel electrophoresis and multilocus sequence typing were used to determine the clonal spread of the isolates. Ten ColR CrKp harboring bla OXA-48 (70%), bla OXA-232 (20%), bla CTX-M (90%), armA (20%), qnrB (20%), and qnrS (50%) were identified. No mcr genes were found, whereas mgrB mutations through modifications (A7T, C88T, and A121G) and insertion of an IS-1-like insertion sequence were determined. Isolates belonged to ST 14, ST 37, ST 101, ST 147, ST 661, ST 985, and ST 2096. It is crucial to determine the antimicrobial resistance properties and the clonal spread of the isolates to guide the treatment decisions, implement effective infection control measures, and develop novel antimicrobial strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeAnti-Bacterial AgentsColistinCarbapenemsKlebsiella InfectionsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity Testsbeta-LactamasesMutationBacterial ProteinsIntensive Care Units, PediatricMultilocus Sequence TypingChildPlasmidsElectrophoresis, Gel, Pulsed-Field

Stichwörter der Autor:innen

Klebsiella pneumoniaeMLSTPFGEantimicrobial resistancecolistin resistancemgrB

Substanzen

Anti-Bacterial AgentsColistinCarbapenemsbeta-LactamasesBacterial Proteins

Autor:innen und Institutionen

  • Republic of Türkiye Ministry of Health, General Directorate of Public Health, National Molecular Microbiology Reference Laboratory, Ankara, Türkiye.
  • Department of Medical Microbiology, Ankara University School of Medicine, Ankara, Türkiye.

ORCID-Profile: Alper Tekeli

Zitieren

APA

Türk, A. H., Tekeli, A., Öcal, D., & Gerçeker, D. (2025). Molecular Characterization of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae : mgrB Mutations and Clonal Diversity in Pediatric Intensive Care Isolates. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0110

Vancouver

Türk AH, Tekeli A, Öcal D, Gerçeker D. Molecular Characterization of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae : mgrB Mutations and Clonal Diversity in Pediatric Intensive Care Isolates. Microbial Drug Resistance. 2025. doi:10.1089/mdr.2024.0110

BibTeX
@article{Trk2025,
  author = {Türk, Ayşe Hande and Tekeli, Alper and Öcal, Duygu and Gerçeker, Devran},
  title = {Molecular Characterization of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae : mgrB Mutations and Clonal Diversity in Pediatric Intensive Care Isolates},
  journal = {Microbial Drug Resistance},
  year = {2025},
  doi = {10.1089/mdr.2024.0110}
}
Kostenlos starten →